Intero Biosystems Wins Startup Battlefield at TechCrunch Disrupt 2026

The tech world gathered in San Francisco this week for the annual TechCrunch Disrupt event, culminating in the intense conclusion of the Startup Battlefield competition. Out of an initial pool of 200 hopeful companies, a carefully curated top 20 took the stage to present live demonstrations before a panel of prominent venture capitalists and technology leaders. Following rigorous deliberations and careful analysis of judge feedback, TechCrunch editors narrowed the field down to five exceptional finalists: Apate, Flox Intelligence, Intero Biosystems, Industrial Next, and Satlyt.

The final showdown featured live demonstrations judged by a high-profile panel consisting of Alexa von Tobel of Inspired Capital, Chi-Hua Chien of Goodwater Capital, Dayna Grayson of Construct Capital, Karl Alomar of M13, and Stacy Brown-Philpot of Cherryrock Capital. After intense scrutiny, Intero Biosystems was crowned the overall winner of Startup Battlefield 2026, taking home the prestigious Startup Battlefield Cup and a $100,000 grand prize.

Intero Biosystems is headquartered in Denver and was founded by Charlie Childs alongside Madeline Eiken. The enterprise originated as a spinout from the University of Michigan, focusing on cutting-edge biotechnology. The company specializes in creating one-millimeter human intestinal organoids, which are laboratory-grown tissues designed to closely mimic the complex functions of the human gut. This technology provides researchers with a highly sophisticated method to study how pharmaceutical drugs and various chemical compounds impact human tissue prior to human clinical trials.

The startup's flagship commercial product is called GastroScreen. It is marketed toward pharmaceutical companies, biotechnology firms, food manufacturers, and chemical enterprises seeking reliable testing platforms. By utilizing these advanced mini-intestines, industries can significantly reduce their reliance on traditional animal testing while gaining more accurate insights into human biological responses. This blend of scientific innovation and clear market application heavily resonated with the judging panel during the competition.

Meanwhile, Australian startup Apate secured the runner-up position with its unique cybersecurity offering. Founded by Dali Kaafar from Macquarie University in Sydney, Apate deploys thousands of sophisticated artificial intelligence agents designed to masquerade as innocent victims. These AI agents actively engage with cybercriminals by answering scam phone calls, responding to fraudulent messages, clicking phishing links, and infiltrating social media groups to actively bait fraudsters and gather actionable intelligence.

By joining the ranks of Startup Battlefield winners, Intero Biosystems and Apate enter a prestigious alumni network that includes industry giants like Trello, Discord, Cloudflare, and Mint. The Startup Battlefield program has a rich history spanning over 1,700 alumni who have collectively raised more than $30 billion in funding and achieved over 200 successful corporate exits. This year's competition once again highlights the incredible potential of early-stage innovators addressing critical challenges across biotech, security, and beyond.